# Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)

> **NCT07639684** · NA · NOT_YET_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 50 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2D)
- Obesity (BMI>30)

## Interventions

- **DEVICE:** ESG with OverStitch

## Key facts

- **NCT ID:** NCT07639684
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-04
- **Primary completion:** 2029-07
- **Final completion:** 2029-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639684, "Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07639684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*